Merck & Co., Inc. (BCBA:MRK)
Argentina · Delayed Price · Currency is ARS 24,280
+340 (1.42%)
Last updated: Sep 17, 2025, 11:00 AM BRT
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Pharmaceutical | 57.40B | Log In | Log In | Log In | Log In | Upgrade |
Pharmaceutical Growth | 1.53% | Log In | Log In | Log In | Log In | Upgrade |
Animal Health | 5.88B | Log In | Log In | Log In | Log In | Upgrade |
Animal Health Growth | 7.88% | Log In | Log In | Log In | Log In | Upgrade |
Other Product | 891.00M | Log In | Log In | Log In | Log In | Upgrade |
Other Product Growth | -16.67% | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
United States | 32.28B | Log In | Log In | Log In | Log In | Upgrade |
United States Growth | 13.68% | Log In | Log In | Log In | Log In | Upgrade |
Europe, Middle East and Africa | 14.04B | Log In | Log In | Log In | Log In | Upgrade |
Europe, Middle East and Africa Growth | 2.86% | Log In | Log In | Log In | Log In | Upgrade |
Latin America | 3.46B | Log In | Log In | Log In | Log In | Upgrade |
Latin America Growth | 3.57% | Log In | Log In | Log In | Log In | Upgrade |
Japan | 3.28B | Log In | Log In | Log In | Log In | Upgrade |
Japan Growth | -5.25% | Log In | Log In | Log In | Log In | Upgrade |
Other Geographic | 2.56B | Log In | Log In | Log In | Log In | Upgrade |
Other Geographic Growth | 14.08% | Log In | Log In | Log In | Log In | Upgrade |
China | 5.49B | Log In | Log In | Log In | Log In | Upgrade |
China Growth | -54.86% | Log In | Log In | Log In | Log In | Upgrade |
Asia Pacific (other than China and Japan) | 3.06B | Log In | Log In | Log In | Log In | Upgrade |
Asia Pacific (other than China and Japan) Growth | 1.90% | Log In | Log In | Log In | Log In | Upgrade |
Other
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2012 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2012 - 2019 |
Other | - | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Other | - | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Pharmaceutical Segment Profit | 44.53B | Log In | Log In | Log In | Log In | Upgrade |
Pharmaceutical Segment Profit Growth | -1.66% | Log In | Log In | Log In | Log In | Upgrade |
Other | - | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Animal Health Segment Profit | 1.94B | Log In | Log In | Log In | Log In | Upgrade |
Animal Health Segment Profit Growth | 16.73% | Log In | Log In | Log In | Log In | Upgrade |
Other Segment Profit | -26.54B | Log In | Log In | Log In | Log In | Upgrade |
Other Segment Profit Growth | 15.89% | Log In | Log In | Log In | Log In | Upgrade |